Todd Franklin Watanabe, President and CEO at Arcutis Biotherapeutics, Inc. (ARQT), sold 269,964 shares at $21.51 ($22K) on 2022-09-07, disclosed to the SEC on 2022-09-09.
Scheduled sale ($22k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 268,964 | $0 | 0.0% |
| 2 | $21.51 | 1,000 | $22K | 100.0% |
| Total | $0.08 avg | 269,964 | $22K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |